2023年9月1日 · Triple vessel coronary artery disease is a severe type of coronary artery disease (CAD). CAD develops when the blood vessels that supply your heart with blood — the coronary...

Genetic and non-genetic predictors of 15-year survival in patients with chronic three-vessel disease (3VD) were investigated. Coronary angiography was performed on 810 subjects with symptoms of stable ischemic heart disease in 1998.

2020年7月9日 · Triple vessel disease is an extreme form of coronary artery disease (CAD). CAD develops when the major blood vessels supplying the heart become damaged or diseased. Plaque (cholesterol deposits) and inflammation are the two main causes of CAD.

冠脉病或冠心病有许多异名或近义词，如：心肌缺血（myocardial ischemia）、缺血性心脏病（ ischemic heart disease ，IHD） [20] 、冠状动脉粥样硬化心脏病（ coronary atherosclerotic heart disease ，CAHD） [21] [22] 、冠状动脉粥样硬化心血管疾病 [23] 等等。

This study evaluated the outcomes after coronary revascularization in patients with 3VD treated by percutaneous coronary intervention (PCI) using second-generation drug-eluting stents (2ndDES) in comparison with coronary artery bypass grafting (CABG). We analyzed 853 patients undergoing either PCI or CABG for 3VD between 2010 and 2014.

We assessed the prevalence, clinical outcomes and predictors of left main and/or three-vessel disease (LM/3VD) in non-ST-elevation acute myocardial infarction (NSTEMI) patients with a GRACE score of ≤108 at admission.

2023年10月11日 · Patients with stable ischemic heart disease (SIHD) and triple vessel disease (TVD) have been recommended coronary artery bypass grafting (CABG) with a view to derive a survival benefit compared to medical therapy [1].

2014年2月3日 · This study shows that in patients with angiographic 3VD, high-resolution perfusion CMR detects a greater ischaemic burden than standard-resolution and more frequently identifies a 3VD pattern of ischaemia due to a higher detection rate of subendocardial ischaemia.

2011年6月1日 · To demonstrate if ST-segment elevation in lead aVR of ⩾0.5 mm and maximal QRS duration of ⩾90 ms, are useful predictors of left main and/or three vessel disease (LM/3VD) in patients presenting with non-ST elevation acute coronary syndrome.

Objectives: To evaluate the efficacy of hemodynamic support using Impella 2.5 (IR2.5) vs intra-aortic balloon pump (IABP) in patients with 3-vessel coronary artery disease (3VD). Background: PROTECT II demonstrated favorable 90-day outcomes in patients with impaired LVEF and left main or 3VD undergoing PCI with hemodynamic support with IR2.5 ...